These findings are consistent with previous studies on the relationship between FANCI and immune infiltration in cervical cancer (Liu et al., 2021), melanoma (Cai et al., 2023), liver cancer (Hou et al., 2023), and lung adenocarcinoma (Ye et al., 2021). This evidence concerns the gene FANCI and cervical cancer.